Zhang Zhao-Xia, Wen Fei-Qiu, Liu Zhi-Ping, Cheng Ying-Duan
Department of Pediatrics, Shenzhen People's Hospital, Jinan University, Shenzhen, Guangdong, 518020, PR China.
Ai Zheng. 2008 Apr;27(4):348-53.
BACKGROUND & OBJECTIVE: Multidrug resistance (MDR) is a major obstacle preventing effective treatment of leukemia. The mechanisms of MDR in leukemic cells have been broadly explored, but they are still unclear. We used proteomic tools to screen MDR-related proteins in vincristine-resistant leukemia cell line K562/VCR, and analyzed the mechanism of MDR in leukemia.
Two-dimensional electrophoresis (2-DE) was used to extract total proteins from K562/VCR and K562 cells. The proteins expressed differentially between the two cell lines were identified by matrix-assisted laser desorption/ionization-time of flight-mass spectrometry (MALDI-TOF-MS). The antisense oligonucleotide (ASO) of the protein was transfected into K562/VCR cells; mis-sense oligonucleotide (MSO) of the protein was also transfected as control. The expression of the protein was detected by Western blot. Cell survival was detected by MTT assay. Cell apoptosis was detected by flow cytometry (FCM).
Heat shock protein 27 (HSP27), a differential expression protein between K562/VCR and K562 cells, was identified. When treated with vincristine, the survival rate of K562/VCR cells was significantly lower in HSP27 ASO group than in HSP27 MSO group (P<0.05). The apoptosis rate of K562/VCR cells was significantly higher in HSP27 ASO group than in HSP27 MSO group (16.37% vs. 3.08%, P<0.05).
HSP27 is highly expressed in K562/VCR cells, and the suppression of its expression by HSP27 ASO could enhance chemosensitivity of K562/VCR cells to vincristine.
多药耐药(MDR)是阻碍白血病有效治疗的主要障碍。白血病细胞中MDR的机制已被广泛研究,但仍不清楚。我们使用蛋白质组学工具筛选长春新碱耐药白血病细胞系K562/VCR中与MDR相关的蛋白质,并分析白血病中MDR的机制。
采用二维电泳(2-DE)从K562/VCR和K562细胞中提取总蛋白。通过基质辅助激光解吸/电离飞行时间质谱(MALDI-TOF-MS)鉴定两种细胞系中差异表达的蛋白质。将该蛋白质的反义寡核苷酸(ASO)转染到K562/VCR细胞中;作为对照,也转染该蛋白质的错义寡核苷酸(MSO)。通过蛋白质免疫印迹法检测该蛋白质的表达。通过MTT法检测细胞存活率。通过流式细胞术(FCM)检测细胞凋亡。
鉴定出热休克蛋白27(HSP27),它是K562/VCR和K562细胞之间的差异表达蛋白。用长春新碱处理时,HSP27 ASO组K562/VCR细胞的存活率明显低于HSP27 MSO组(P<0.05)。HSP27 ASO组K562/VCR细胞的凋亡率明显高于HSP27 MSO组(16.37%对3.08%,P<0.05)。
HSP27在K562/VCR细胞中高表达,HSP27 ASO抑制其表达可增强K562/VCR细胞对长春新碱的化疗敏感性。